Acizide-TZ 281.25 Injection
Marketer
Accilex Nutricorp
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Acizide-TZ 281.25 Injection
Tazicef 281.25mg injectable solution is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial proliferation and halting infection progression. Administration of Tazicef 281.25mg injection must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire treatment course is vital, even with symptom improvement. Premature cessation may compromise treatment efficacy. Common adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects promptly to your physician. Seek immediate medical attention for allergic reactions (e.g., skin rashes, pruritus, edema, respiratory distress). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor might order lab tests and imaging to monitor treatment response.
Uses of Acizide-TZ 281.25 Injection
Infections caused by bacteria
Major Benefits of Acizide-TZ 281.25 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Acizide-TZ 281.25 Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Acizide-TZ 281.25 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Acizide-TZ 281.25 Injection works:
Acizide-TZ 281.25 Injection unites Ceftazidime, a crucial antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, a vital process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thus bolstering Ceftazidime's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Acizide-TZ 281.25 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Acizide-TZ 281.25 is usually deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for the fetus; however, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Acizide-TZ 281.25 is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no identified risk to the infant.
DrivingUNSAFE
The administration of Acizide-TZ 281.25 Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
TZ-281.25 Acizide injections require careful administration for individuals with impaired renal function. Dosage modifications for TZ-281.25 Acizide injections may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Acizide-TZ 281.25 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Acizide-TZ 281.25 Injection :
Omitting a scheduled dose of Acizide-TZ 281.25 Injection warrants immediate physician consultation.
Facts to Know About Acizide-TZ 281.25 Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial Agents |
3,018 People bought this recently